No Record Found
Sector
PharmaceuticalsOpen
₹1,511.6Prev. Close
₹1,504.3Turnover(Lac.)
₹33.01Day's High
₹1,564Day's Low
₹1,505.152 Week's High
₹2,14052 Week's Low
₹957Book Value
₹464.82Face Value
₹5Mkt Cap (₹ Cr.)
951.23P/E
53.2EPS
29.05Divi. Yield
0.11No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | 
|---|---|---|---|---|
Equity Capital  | 3.09  | 3.09  | 3.09  | 3.09  | 
Preference Capital  | 0  | 0  | 0  | 0  | 
Reserves  | 276.52  | 259.72  | 222.43  | 203.48  | 
Net Worth  | 279.61  | 262.81  | 225.52  | 206.57  | 
Minority Interest  | 
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 | 
|---|---|---|---|---|
Revenue  | 318.66  | 258.18  | 152.18  | 113.65  | 
yoy growth (%)  | 23.42  | 69.65  | 33.89  | 13.97  | 
Raw materials  | -148.31  | -102.5  | -64.8  | -45.86  | 
As % of sales  | 46.54  | 39.7  | 42.58  | 40.35  | 
Employee costs  | -33.05  | -27.23  | -23.8  | -18.37  | 
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 | 
|---|---|---|---|---|
Profit before tax  | 68.97  | 75.99  | 14.35  | 17.8  | 
Depreciation  | -7.67  | -7.39  | -7.26  | -4.56  | 
Tax paid  | -16.72  | -20.52  | -3.74  | -5.2  | 
Working capital  | 39.27  | 16.39  | 25.59  | -4.17  | 
Other operating items  | 
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 | 
|---|---|---|---|---|
Growth matrix (%)  | ||||
Revenue growth  | 23.42  | 69.65  | 33.89  | 13.97  | 
Op profit growth  | -14.49  | 273.41  | -3.79  | -15.26  | 
EBIT growth  | -9.38  | 368.73  | -14.21  | -17.74  | 
Net profit growth  | -5.81  | 423.11  | -15.79  | -15.4  | 
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | 
|---|---|---|---|---|---|
Gross Sales  | 368.26  | 338.69  | 278.08  | 317.5  | 257.97  | 
Excise Duty  | 0  | 0  | 0  | 0  | 0  | 
Net Sales  | 368.26  | 338.69  | 278.08  | 317.5  | 257.97  | 
Other Operating Income  | 0  | 0  | 0  | 0  | 0  | 
Other Income  | 8.63  | 14.13  | 5.53  | 10.68  | 8.02  | 
Company Name  | LTP (₹)  | P/E  (%)  | Mkt.Cap  (₹Cr.)  | NP Qtr (₹Cr.)  | Div.Yield  (%)  | Sales Qtr  (₹.Cr)  | Book Value (₹)  | 
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA  | 1,690.7  | 81.4 | 4,05,451.62 | 753.53 | 0.95 | 5,566.68 | 101.44 | 
Divis Laboratories Ltd DIVISLAB  | 6,738  | 76.66 | 1,79,089.09 | 557 | 0.44 | 2,357 | 561.08 | 
Cipla Ltd CIPLA  | 1,501.3  | 23.34 | 1,21,298.96 | 1,210.53 | 1.07 | 4,495.16 | 411.56 | 
Torrent Pharmaceuticals Ltd TORNTPHARM  | 3,560.1  | 60.59 | 1,20,450.71 | 551 | 0.17 | 2,567 | 224.34 | 
Dr Reddys Laboratories Ltd DRREDDY  | 1,197.6  | 18.52 | 99,965.86 | 387.3 | 0.67 | 4,602.9 | 377.57 | 
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
Rahul J Nachane
Whole Time Director & Chief Financial Officer
Rajesh N Lawande
Non-Executive & Non-Independent Director
Ajita Nachane
Non Executive & Independent Director
Jayaram Sitaram
Company Sec. & Compli. Officer
Pallavi Pednekar
Independent Director
Sarala Menon
Chairman & Independent Director
Dhananjay Mungale
Additional Director
S R Deo
301 E Square Subhash Road,
Vile Parle (East),
Maharashtra - 400057
Tel: +91-22-2663 6450
Website: http://www.nglfinechem.com
Email: info@nglfinechem.com
Shiv Shakti Indust,
Unit No 9 Lower Pare, 7 B J R Boricha Marg,
Mumbai-400011
Tel: 91-022-23016761
Website: www.purvashare.com
Email: busicomp@vsnl.com
Summary
NGL Fine-Chem Limited was incorporated on December 18, 1981 as a Private Limited Company in the State of Maharashtra. The Company became a Public Limited Company. The Company has got its registered of...
Read More
Reports by NGL Fine Chem Ltd
 IIFL Customer Care Number 
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000  / 7039-050-000
 IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.